Annual SG&A
$6.38 M
-$913.10 K-12.52%
31 December 2023
Summary:
ProMIS Neurosciences annual selling, general & administrative expenses is currently $6.38 million, with the most recent change of -$913.10 thousand (-12.52%) on 31 December 2023. During the last 3 years, it has risen by +$4.43 million (+227.88%). PMN annual SG&A is now -12.52% below its all-time high of $7.29 million, reached on 31 December 2022.PMN Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$1.87 M
+$783.00 K+71.97%
30 September 2024
Summary:
ProMIS Neurosciences quarterly selling, general & administrative expenses is currently $1.87 million, with the most recent change of +$783.00 thousand (+71.97%) on 30 September 2024. Over the past year, it has increased by +$495.50 thousand (+36.03%). PMN quarterly SG&A is now -12.51% below its all-time high of $2.14 million, reached on 31 December 2022.PMN Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$380.74 M
-$563.40 K-0.15%
30 September 2024
Summary:
ProMIS Neurosciences TTM selling, general & administrative expenses is currently -$380.74 million, with the most recent change of -$563.40 thousand (-0.15%) on 30 September 2024. Over the past year, it has dropped by -$387.61 million (-5643.37%). PMN TTM SG&A is now -110.11% below its all-time high of $7.29 million, reached on 31 December 2022.PMN TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PMN Selling, General & Administrative Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -12.5% | +36.0% | -5643.4% |
| 3 y3 years | +227.9% | +47.8% | -10000.0% |
| 5 y5 years | +215.1% | +323.7% | -10000.0% |
PMN Selling, General & Administrative Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -12.5% | +227.9% | -12.5% | +72.0% | -55.4% | at low |
| 5 y | 5 years | -12.5% | +227.9% | -12.5% | +508.0% | -106.7% | at low |
| alltime | all time | -12.5% | +1714.5% | -12.5% | +8252.2% | -110.1% | at low |
ProMIS Neurosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $1.87 M(+72.0%) | $6.16 M(+8.7%) |
| June 2024 | - | $1.09 M(-29.9%) | $5.67 M(-12.5%) |
| Mar 2024 | - | $1.55 M(-5.9%) | $6.47 M(+1.4%) |
| Dec 2023 | $6.38 M(-12.5%) | $1.65 M(+19.9%) | $6.38 M(-7.1%) |
| Sept 2023 | - | $1.38 M(-27.4%) | $6.87 M(-1.6%) |
| June 2023 | - | $1.89 M(+29.7%) | $6.98 M(+3.9%) |
| Mar 2023 | - | $1.46 M(-31.7%) | $6.72 M(-7.9%) |
| Dec 2022 | $7.29 M(+99.1%) | $2.14 M(+44.1%) | $7.29 M(+6.4%) |
| Sept 2022 | - | $1.48 M(-9.3%) | $6.85 M(+3.3%) |
| June 2022 | - | $1.64 M(-19.7%) | $6.63 M(+24.0%) |
| Mar 2022 | - | $2.04 M(+19.8%) | $5.35 M(+47.7%) |
| Dec 2021 | $3.66 M(+88.3%) | $1.70 M(+34.2%) | $3.62 M(+55.0%) |
| Sept 2021 | - | $1.27 M(+260.4%) | $2.34 M(+60.9%) |
| June 2021 | - | $351.10 K(+14.1%) | $1.45 M(-12.1%) |
| Mar 2021 | - | $307.70 K(-25.5%) | $1.65 M(-13.1%) |
| Dec 2020 | $1.95 M(-4.5%) | $413.00 K(+8.3%) | $1.90 M(-2.9%) |
| Sept 2020 | - | $381.20 K(-30.8%) | $1.96 M(-3.0%) |
| June 2020 | - | $551.20 K(-0.8%) | $2.02 M(-3.4%) |
| Mar 2020 | - | $555.90 K(+18.4%) | $2.09 M(+2.4%) |
| Dec 2019 | $2.04 M(+0.6%) | - | - |
| Dec 2019 | - | $469.40 K(+6.3%) | $2.04 M(+28.1%) |
| Sept 2019 | - | $441.60 K(-28.9%) | $1.59 M(-18.7%) |
| June 2019 | - | $621.50 K(+22.8%) | $1.96 M(+5.5%) |
| Mar 2019 | - | $506.20 K(+2159.8%) | $1.86 M(-7.9%) |
| Dec 2018 | $2.02 M(+9.8%) | - | - |
| Dec 2018 | - | $22.40 K(-97.2%) | $2.02 M(-15.2%) |
| Sept 2018 | - | $808.50 K(+55.5%) | $2.38 M(+26.1%) |
| June 2018 | - | $519.90 K(-21.8%) | $1.88 M(-3.6%) |
| Mar 2018 | - | $665.10 K(+73.6%) | $1.96 M(+10.9%) |
| Dec 2017 | $1.84 M(+57.2%) | $383.10 K(+21.2%) | $1.76 M(+1.1%) |
| Sept 2017 | - | $316.10 K(-46.5%) | $1.74 M(+2.2%) |
| June 2017 | - | $591.00 K(+25.1%) | $1.71 M(+20.3%) |
| Mar 2017 | - | $472.30 K(+29.9%) | $1.42 M(+20.1%) |
| Dec 2016 | $1.17 M(+71.9%) | $363.70 K(+30.4%) | $1.18 M(+12.4%) |
| Sept 2016 | - | $278.90 K(-8.0%) | $1.05 M(+1.8%) |
| June 2016 | - | $303.10 K(+29.0%) | $1.03 M(+20.8%) |
| Mar 2016 | - | $234.90 K(+0.4%) | $854.30 K(+22.8%) |
| Dec 2015 | $682.30 K | $233.90 K(-10.2%) | $695.90 K(+50.6%) |
| Sept 2015 | - | $260.50 K(+108.4%) | $462.00 K(-8.1%) |
| June 2015 | - | $125.00 K(+63.4%) | $502.70 K(-41.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2015 | - | $76.50 K(-74.6%) | $860.70 K(-36.1%) |
| Dec 2014 | $931.10 K(+3.7%) | - | - |
| Sept 2014 | - | $301.20 K(-37.6%) | $1.35 M(+11.8%) |
| June 2014 | - | $483.00 K(+21.5%) | $1.20 M(+33.1%) |
| Mar 2014 | $898.10 K(+88.6%) | $397.40 K(+141.1%) | $905.20 K(+46.9%) |
| Dec 2013 | - | $164.80 K(+3.4%) | $616.10 K(+10.8%) |
| Sept 2013 | - | $159.40 K(-13.2%) | $556.00 K(+7.0%) |
| June 2013 | - | $183.60 K(+69.5%) | $519.80 K(+9.6%) |
| Mar 2013 | $476.10 K(-22.2%) | $108.30 K(+3.4%) | $474.30 K(-14.4%) |
| Dec 2012 | - | $104.70 K(-15.0%) | $554.10 K(-10.3%) |
| Sept 2012 | - | $123.20 K(-10.8%) | $617.80 K(+2.9%) |
| June 2012 | - | $138.10 K(-26.6%) | $600.30 K(-33.5%) |
| Mar 2012 | $612.20 K(-32.2%) | $188.10 K(+11.7%) | $902.60 K(+19.9%) |
| Dec 2011 | - | $168.40 K(+59.3%) | $753.10 K(-6.4%) |
| Sept 2011 | - | $105.70 K(-76.0%) | $804.30 K(-24.9%) |
| June 2011 | - | $440.40 K(+1040.9%) | $1.07 M(+21.9%) |
| Mar 2011 | $902.80 K(-22.8%) | $38.60 K(-82.4%) | $877.70 K(-27.0%) |
| Dec 2010 | - | $219.60 K(-40.9%) | $1.20 M(-1.3%) |
| Sept 2010 | - | $371.70 K(+50.0%) | $1.22 M(+7.5%) |
| June 2010 | - | $247.80 K(-31.8%) | $1.13 M(-0.2%) |
| Mar 2010 | $1.17 M(+42.0%) | $363.20 K(+53.9%) | $1.14 M(+12.8%) |
| Dec 2009 | - | $236.00 K(-17.8%) | $1.01 M(+7.7%) |
| Sept 2009 | - | $287.00 K(+14.6%) | $936.40 K(+5.3%) |
| June 2009 | - | $250.50 K(+6.8%) | $889.20 K(-0.9%) |
| Mar 2009 | $824.00 K(-32.6%) | $234.60 K(+42.8%) | $897.70 K(-0.4%) |
| Dec 2008 | - | $164.30 K(-31.5%) | $901.10 K(-3.0%) |
| Sept 2008 | - | $239.80 K(-7.4%) | $928.70 K(-16.8%) |
| June 2008 | - | $259.00 K(+8.8%) | $1.12 M(-6.8%) |
| Mar 2008 | $1.22 M(+38.2%) | $238.00 K(+24.0%) | $1.20 M(-12.0%) |
| Dec 2007 | - | $191.90 K(-55.1%) | $1.36 M(+0.3%) |
| Sept 2007 | - | $427.00 K(+25.7%) | $1.36 M(+25.9%) |
| June 2007 | - | $339.80 K(-15.3%) | $1.08 M(+19.8%) |
| Mar 2007 | $885.50 K(+151.8%) | $401.40 K(+113.7%) | $898.90 K(+46.0%) |
| Dec 2006 | - | $187.80 K(+26.7%) | $615.80 K(+6.8%) |
| Sept 2006 | - | $148.20 K(-8.2%) | $576.70 K(+20.9%) |
| June 2006 | - | $161.50 K(+36.5%) | $476.90 K(+36.4%) |
| Mar 2006 | $351.60 K | $118.30 K(-20.4%) | $349.60 K(+51.1%) |
| Dec 2005 | - | $148.70 K(+207.2%) | $231.30 K(+180.0%) |
| Sept 2005 | - | $48.40 K(+41.5%) | $82.60 K(+141.5%) |
| June 2005 | - | $34.20 K | $34.20 K |
FAQ
- What is ProMIS Neurosciences annual selling, general & administrative expenses?
- What is the all time high annual SG&A for ProMIS Neurosciences?
- What is ProMIS Neurosciences annual SG&A year-on-year change?
- What is ProMIS Neurosciences quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for ProMIS Neurosciences?
- What is ProMIS Neurosciences quarterly SG&A year-on-year change?
- What is ProMIS Neurosciences TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for ProMIS Neurosciences?
- What is ProMIS Neurosciences TTM SG&A year-on-year change?
What is ProMIS Neurosciences annual selling, general & administrative expenses?
The current annual SG&A of PMN is $6.38 M
What is the all time high annual SG&A for ProMIS Neurosciences?
ProMIS Neurosciences all-time high annual selling, general & administrative expenses is $7.29 M
What is ProMIS Neurosciences annual SG&A year-on-year change?
Over the past year, PMN annual selling, general & administrative expenses has changed by -$913.10 K (-12.52%)
What is ProMIS Neurosciences quarterly selling, general & administrative expenses?
The current quarterly SG&A of PMN is $1.87 M
What is the all time high quarterly SG&A for ProMIS Neurosciences?
ProMIS Neurosciences all-time high quarterly selling, general & administrative expenses is $2.14 M
What is ProMIS Neurosciences quarterly SG&A year-on-year change?
Over the past year, PMN quarterly selling, general & administrative expenses has changed by +$495.50 K (+36.03%)
What is ProMIS Neurosciences TTM selling, general & administrative expenses?
The current TTM SG&A of PMN is -$380.74 M
What is the all time high TTM SG&A for ProMIS Neurosciences?
ProMIS Neurosciences all-time high TTM selling, general & administrative expenses is $7.29 M
What is ProMIS Neurosciences TTM SG&A year-on-year change?
Over the past year, PMN TTM selling, general & administrative expenses has changed by -$387.61 M (-5643.37%)